Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability

Yurong Song1, Shaneen S Baxter1, Lisheng Dai1

  • 1Cancer ImmunoPrevention Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.

Cancers
|July 9, 2022
PubMed

Insights

A new mouse model rapidly develops malignant mesothelioma without asbestos exposure, offering insights into cancer development and potential early detection methods using plasma markers.

Area of Science:

  • Oncology
  • Genetics
  • Animal Models

Background:

  • Malignant mesothelioma (MMe) is a rare cancer linked to asbestos exposure.
  • Existing mouse models often require asbestos and long development times.
  • A need exists for efficient MMe models that mimic human disease.

Purpose of the Study:

  • To characterize a novel orthotopic MMe model.
  • To assess genomic instability in the MMe model.
  • To evaluate plasma microsatellite markers for cancer detection.

Main Methods:

  • Developed an orthotopic MMe model using cells from Cdkn2a mice.
  • Injected MMe cells intraperitoneally into immunocompetent mice.
  • Analyzed chromosomal and microsatellite instability.
  • Detected microsatellite markers in plasma.

Main Results:

  • The orthotopic model rapidly developed MMe without asbestos.
  • MMe cells exhibited mixed chromosomal and microsatellite instability.
  • Plasma microsatellite markers were detectable in tumor-bearing mice.

Conclusions:

  • This model recapitulates MMe genomic instability and rapid tumor development.
  • The model is suitable for preclinical testing of interventions.
  • Plasma microsatellite markers show potential for early cancer detection and monitoring.